These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

439 related items for PubMed ID: 15930299

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Novel synthetic pyridyl analogues of CDDO-Imidazolide are useful new tools in cancer prevention.
    Cao M, Onyango EO, Williams CR, Royce DB, Gribble GW, Sporn MB, Liby KT.
    Pharmacol Res; 2015 Oct; 100():135-47. PubMed ID: 26238177
    [Abstract] [Full Text] [Related]

  • 4. Pharmacodynamic characterization of chemopreventive triterpenoids as exceptionally potent inducers of Nrf2-regulated genes.
    Yates MS, Tauchi M, Katsuoka F, Flanders KC, Liby KT, Honda T, Gribble GW, Johnson DA, Johnson JA, Burton NC, Guilarte TR, Yamamoto M, Sporn MB, Kensler TW.
    Mol Cancer Ther; 2007 Jan; 6(1):154-62. PubMed ID: 17237276
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The triterpenoid CDDO-imidazolide ameliorates mouse liver ischemia-reperfusion injury through activating the Nrf2/HO-1 pathway enhanced autophagy.
    Xu D, Chen L, Chen X, Wen Y, Yu C, Yao J, Wu H, Wang X, Xia Q, Kong X.
    Cell Death Dis; 2017 Aug 10; 8(8):e2983. PubMed ID: 28796242
    [Abstract] [Full Text] [Related]

  • 8. Synthetic triterpenoids enhance transforming growth factor beta/Smad signaling.
    Suh N, Roberts AB, Birkey Reffey S, Miyazono K, Itoh S, ten Dijke P, Heiss EH, Place AE, Risingsong R, Williams CR, Honda T, Gribble GW, Sporn MB.
    Cancer Res; 2003 Mar 15; 63(6):1371-6. PubMed ID: 12649201
    [Abstract] [Full Text] [Related]

  • 9. CDDO-Im protects from acetaminophen hepatotoxicity through induction of Nrf2-dependent genes.
    Reisman SA, Buckley DB, Tanaka Y, Klaassen CD.
    Toxicol Appl Pharmacol; 2009 Apr 01; 236(1):109-14. PubMed ID: 19371629
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The triterpenoid CDDO-imidazolide confers potent protection against hyperoxic acute lung injury in mice.
    Reddy NM, Suryanaraya V, Yates MS, Kleeberger SR, Hassoun PM, Yamamoto M, Liby KT, Sporn MB, Kensler TW, Reddy SP.
    Am J Respir Crit Care Med; 2009 Nov 01; 180(9):867-74. PubMed ID: 19679692
    [Abstract] [Full Text] [Related]

  • 12. CDDO-Im exerts antidepressant-like effects via the Nrf2/ARE pathway in a rat model of post-stroke depression.
    Hou X, Liu H, Ping Y, Zhang F, Zhi L, Jiang X, Zhang F, Song C, Zhang Z, Song J.
    Brain Res Bull; 2021 Aug 01; 173():74-81. PubMed ID: 33991607
    [Abstract] [Full Text] [Related]

  • 13. The novel synthetic triterpenoid, CDDO-imidazolide, inhibits inflammatory response and tumor growth in vivo.
    Place AE, Suh N, Williams CR, Risingsong R, Honda T, Honda Y, Gribble GW, Leesnitzer LM, Stimmel JB, Willson TM, Rosen E, Sporn MB.
    Clin Cancer Res; 2003 Jul 01; 9(7):2798-806. PubMed ID: 12855660
    [Abstract] [Full Text] [Related]

  • 14. Dimethyl fumarate and the oleanane triterpenoids, CDDO-imidazolide and CDDO-methyl ester, both activate the Nrf2 pathway but have opposite effects in the A/J model of lung carcinogenesis.
    To C, Ringelberg CS, Royce DB, Williams CR, Risingsong R, Sporn MB, Liby KT.
    Carcinogenesis; 2015 Jul 01; 36(7):769-81. PubMed ID: 25939751
    [Abstract] [Full Text] [Related]

  • 15. Role of Nrf2 in prevention of high-fat diet-induced obesity by synthetic triterpenoid CDDO-imidazolide.
    Shin S, Wakabayashi J, Yates MS, Wakabayashi N, Dolan PM, Aja S, Liby KT, Sporn MB, Yamamoto M, Kensler TW.
    Eur J Pharmacol; 2009 Oct 12; 620(1-3):138-44. PubMed ID: 19698707
    [Abstract] [Full Text] [Related]

  • 16. Neuroprotective role of Nrf2 for retinal ganglion cells in ischemia-reperfusion.
    Xu Z, Cho H, Hartsock MJ, Mitchell KL, Gong J, Wu L, Wei Y, Wang S, Thimmulappa RK, Sporn MB, Biswal S, Welsbie DS, Duh EJ.
    J Neurochem; 2015 Apr 12; 133(2):233-41. PubMed ID: 25683606
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The synthetic triterpenoid CDDO-imidazolide induces monocytic differentiation by activating the Smad and ERK signaling pathways in HL60 leukemia cells.
    Ji Y, Lee HJ, Goodman C, Uskokovic M, Liby K, Sporn M, Suh N.
    Mol Cancer Ther; 2006 Jun 12; 5(6):1452-8. PubMed ID: 16818503
    [Abstract] [Full Text] [Related]

  • 19. Synthetic triterpenoids cooperate with tumor necrosis factor-related apoptosis-inducing ligand to induce apoptosis of breast cancer cells.
    Hyer ML, Croxton R, Krajewska M, Krajewski S, Kress CL, Lu M, Suh N, Sporn MB, Cryns VL, Zapata JM, Reed JC.
    Cancer Res; 2005 Jun 01; 65(11):4799-808. PubMed ID: 15930300
    [Abstract] [Full Text] [Related]

  • 20. Nrf2-dependent protection from LPS induced inflammatory response and mortality by CDDO-Imidazolide.
    Thimmulappa RK, Scollick C, Traore K, Yates M, Trush MA, Liby KT, Sporn MB, Yamamoto M, Kensler TW, Biswal S.
    Biochem Biophys Res Commun; 2006 Dec 29; 351(4):883-9. PubMed ID: 17097057
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.